Implantable vascular device

• US 5,713,859 A
• Filed: 04/18/1996
• Issued: 02/03/1998
• Est. Priority Date: 01/18/1994
• Status: Expired due to Term

• Current Assignee: Vasca Inc.
• Original Assignee: Vasca Inc.
• Inventors: Kuiper, Hendrik Klaas, Finch, Charles David Jr.
• Primary Examiner(s): JONES, MARYBETH O
• Application Number:
  US08/634,634
• Time in Patent Office: 656 Days
• Field of Search: 604/4-6, 604/9, 604/52, 604/53, 604/93, 604/175, 604/183, 604/247, 604/905, 623/1
• US Class Current: 604/93.01
• CPC Class Codes: A61F 2/064 with special features to facilitate anastomotic coupling anastomosis of natural blood vessels A61B17/11
• CPC Class Codes: A61M 2039/0211 with multiple chambers in a single site
• CPC Class Codes: A61M 2039/0223 having means for anchoring the subcutaneous access site
• CPC Class Codes: A61M 39/0208 Subcutaneous access sites for injecting or removing fluids transcutaneous access sites A61M39/0247; implantable infusion devices A61M5/14276
• CPC Class Codes: Y10S 604/905 Aseptic connectors or couplings, e.g. frangible, piercable
• CPC Class Codes: Y10S 623/903 Blood vessel

Abstract

An implantable device grafted directly to vascular structures for high volume blood and/or fluid infusion and/or removal for such purpose as hemodialysis, apheresis, exchange transfusion, or large volume fluid infusion. The device is also adaptable to intermittent access to the venous or arterial circulations for purpose of blood sampling or giving medications. The device is comprised of an implantable fluid chamber connected to a cannula or shunt segment which is then grafted directly to the vascular structure (e.g. artery or vein) using a sewable cuff located at the vascular end of the cannula or shunt segment. The vascular end of the device employs a valve which is directly adjacent to the vascular structure after grafting, in order to prevent reflux of blood and subsequent washout of anticoagulant during periods when the device is not in use. The device is accessed percutaneously with a needle or needle-introduced catheter and is filled with anti-coagulant prior to needle withdrawal to prevent thrombosis.

Claims

1. A method for performing extracorporeal blood treatment, said method comprising:

percutaneously attaching a first catheter to a first subcutaneously implanted port, wherein said first port is connected to an artery by a cannula;

percutaneously attaching a second catheter to a second subcutaneously implanted port, wherein said second port is connected to a vein by a cannula; and

circulating blood from the first catheter through an extracorporeal circuit to the second catheter.

2. A method as in claim 1, wherein at least the first catheter is accessed by penetrating a needle or a needle-introduced catheter.

3. A method as in claim 2, wherein the port comprises a penetrable membrane and the needle or needle-introduced catheter is penetrated through the membrane.

4. A method as in claim 1, wherein the extracorporeal circuit is a hemodialysis circuit an apheresis circuit, or an exchange transfusion circuit.

5. A method as in claim 1, further comprising stopping circulation and filling at least the arterial cannula with an anti-coagulant fluid.

6. A method as in claim 5, wherein the anti-coagulant fluid is maintained within the cannula by a valve disposed near the distal end thereof.

7. A method for implanting an arterial port and a venous port to establish connections for an extracorporeal blood treatment circuit, said method comprising:

surgically implanting a first port capable of percutaneously receiving attachment of a first catheter;

surgically attaching one end of a first cannula to an artery, wherein the other end of the cannula is attached to the first port;

surgically implanting a second port capable of percutaneously receiving attachment of a second cannula;

connecting one end of a second cannula to a vein, wherein the other end of the second cannula is attached to the second port; and

surgically closing the sites at which the ports and the cannulas have been implanted.

8. A method as in claim 7, wherein the first cannula is attached to the artery without substantial intrusion into the arterial lumen.

9. A method as in claim 8, wherein the one end of the first catheter is attached to the artery by grafting in an end-to-side manner.

10. A method as in claim 7, wherein the first cannula includes a valve near its arterial connection to inhibit reflux of blood when the blood is not being drawn through the first port.

11. A method as in claim 10, wherein the arterial and venous connections are disposed at anatomically remote sites.

12. A method for implanting an arterial port, said method comprising:

surgically implanting a port capable of percutaneously receiving attachment of a catheter;

surgically attaching one end of a cannula to an artery without substantial intrusion into the arterial lumen, wherein the other end of the cannula is attached to the port and the one end has a valve to inhibit blood reflux into the cannula in the absence of blood flow through the port; and

surgically closing the sites at which the port and the cannula have been implanted.

13. A method as in claim 12, wherein the one end of the cannula is attached to the artery by suturing in an end-to-side anastomosis.

14. A method as in claim 12, wherein the valve is a slit valve extending across the cannnula near its distal end.

15. A method for administering medication into an artery, said method comprising;

percutaneously attaching a needle or needle-introduced catheter to a subcutaneously implanted port, wherein said port is connected to the artery by a cannula having a valve near its distal connection to said artery to inhibit blood reflux when medication is not being administered therethrough and wherein the cannula is connected to the artery without substantial intrusion into the arterial lumen; and

infusing a fluid medication through the needle or needle-introduced catheter into the port and to the artery.

16. A method as in claim 15, wherein the valve is a slit valve extending across the cannula near the distal end.

17. A method as in claim 16, further comprising filling the cannula with an anti-coagulant fluid when medication is not being introduced therethrough.